drugset / Trial / NCT05522556

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

NCT05522556

Expanded access Available Pfizer

Summary

Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritlecitinib Small molecule

Indications